Literature DB >> 8920208

Activation of programmed (apoptotic) cell death for the treatment of prostate cancer.

S R Denmeade1, J T Isaacs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8920208     DOI： 10.1016/s1054-3589(08)60278-1

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  7 in total

1.  Differential effects of specific amino acid restriction on glucose metabolism, reduction/oxidation status and mitochondrial damage in DU145 and PC3 prostate cancer cells.

Authors:  Xiaoyi Liu; Ya-Min Fu; Gary G Meadows
Journal:  Oncol Lett       Date:  2011-01-18       Impact factor: 2.967

2.  Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.

Authors:  S R Denmeade; W Lou; J Lövgren; J Malm; H Lilja; J T Isaacs
Journal:  Cancer Res       Date:  1997-11-01       Impact factor: 12.701

3.  Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.

Authors:  Boris Risek; Piotr Bilski; Annette B Rice; William T Schrader
Journal:  Mol Endocrinol       Date:  2008-06-18

Review 4.  Role of the Bcl-2 gene family in prostate cancer progression and its implications for therapeutic intervention.

Authors:  K S Chaudhary; P D Abel; E N Lalani
Journal:  Environ Health Perspect       Date:  1999-02       Impact factor: 9.031

5.  CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells.

Authors:  D J Barakat; J Zhang; T Barberi; S R Denmeade; A D Friedman; I Paz-Priel
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

Review 6.  Cholesterol and Its Metabolites in Tumor Growth: Therapeutic Potential of Statins in Cancer Treatment.

Authors:  Adele Chimento; Ivan Casaburi; Paola Avena; Francesca Trotta; Arianna De Luca; Vittoria Rago; Vincenzo Pezzi; Rosa Sirianni
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-21       Impact factor: 5.555

7.  Interaction of TLK1 and AKTIP as a Potential Regulator of AKT Activation in Castration-Resistant Prostate Cancer Progression.

Authors:  Md Imtiaz Khalil; Christopher Madere; Ishita Ghosh; Rosalyn M Adam; Arrigo De Benedetti
Journal:  Pathophysiology       Date:  2021-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.